学会発表・講義（国際）

American Society of Clinical Oncology Annual Meeting（ASCO2021）

June 4-8, 2021（virtual）

Phase I/II study to evaluate the efficacy of TAS0313, a cancer peptide vaccine, combined with pembrolizumab for locally advanced or metastatic urothelial carcinoma.
Ryuji Matsumoto, Junji Yonese, Takashi Kawahara, Hideaki Miyake, Nobuaki Matsubara, Hiroji Uemura, Masatoshi Eto, Haruhito Azuma, Wataru Obara, Akito Terai, Satoshi Fukasawa, Shigetaka Suekane, Hiroyuki Nishiyama.

American Transplant Congress（ATC2021）

June 4-9, 2021（Virtual）

Novel mixed lymphocyte reaction monitoring system that predicts chronic antibody- mediated rejection in kidney transplant recipients.
Naoya Iwahara, Kiyohiko Hotta, Tatsu Tanabe, Daiki Iwami, Yusuke Takada, Haruka Higuchi, Hajime Sasaki, Hiroshi Harada, Nobuo Shinohara.

Successful Induction of Hematopoietic Chimerism by Dual Inhibition of Mcl-1 and Bcl-2 without myeloablative treatments in nonhuman primates.
Hirose T, Lassiter G, Ma D, Kawai T.

Successful Long-Term TMA- and Rejection-Free Survival of a Kidney Xenograft with Triple Xenoantigen Knockout Plus Insertion of Multiple Transgenes.
Hirose T, Ma D, Lassiter G, Sasaki H, Rosales I, Coe TM, Rickert CG, Matheson R, Colvin RB, Qin W, Kan Y, Layer JV, Paragas VB, Stiede K, Hall KC, Youd ME, Queiroz LM, Westlin WF, Curtis M, Yang L, Markmann JF, Kawai T.

Hematopoietic Stem Cells Depletion by Bcl-2 Inhibitor.
Hirose T, Lassiter G, Ma D, Sasaki H, Kawai T.

American Urological Association（AUA2021）

September 10-13, 2021（Virtual）

Efficacy of nivolumab plus ipilimumab in primary tumor as first-line therapy in the patients with advanced renal cell carcinoma.
Hiroshi Kikuchi, Takahiro Osawa, Ryuji Matsumoto, Takashige Abe, Satoru Maruyama, Toru Harabayashi, Haruka Miyata, Akira Kashiwagi, Ataru Sazawa, Riyo Fukui, Ken Morita, Ichiro Takeuchi, Noboru Yamashita, Keita Minami, Tango Mochizuki, Nobuo Shinohara.

World Congress of Endourology（WCET 2021）

September 23-25, 2021（Virtual）

Comparison of renal functional outcomes between warm and cold ischemia following minimally invasive partial nephrectomy.
Ryuji Matsumoto, Takashige Abe, Shuhei Yamada, Jun Furumido, Hiroshi Kikuchi, Takahiro Osawa, Nobuo Shinohara.

International Xenotransplantation Association and the Cell Transplant and Regenerative Medicine Society Joint Virtual Congress (IXA/CTRMS 2021)

September 24, 2021（Virtual）

Graft Survival of the Kidney Xenografts with Triple Xenoantigen Knockout and Multiple Human Transgenes in Cynomolgus Monkeys.
Hirose T, Ma D, Lassiter G, Sasaki H, Rosales I, Coe TM, Rickert CG, Matheson R, Colvin RB, Qin W, Kan Y, Layer JV, Paragas VB, Stiede K, Hall KC, Youd ME, Queiroz LM, Westlin WF, Curtis M, Yang L, Markmann JF, Kawai T.

The New Era of I-O drug combination treatment -WHAT WOULD YOU DO FIRST?-

October（Sapporo, Japan）

How can we select first line treatment in metastatic RCC?
篠原信雄